Call for comments on the Zika virus (ZIKV) Research and Development (R&D) Roadmap
A call for comments has been launched on the draft Zika virus (ZIKV) Research and Development (R&D) Roadmap developed by The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, the University of Texas Medical Branch (UTMB), an expert team of taskforce members from around the world, and the World Health Organization (WHO).
The aim of the roadmap, a key component of the WHO’s R&D Blueprint, is to accelerate ‘the development and implementation of effective medical countermeasures for ZIKV’. This includes the development of diagnostics, therapeutic agents, and vaccines to reduce the morbidity, mortality and transmission of the disease.
Comments should be submitted in English no later than Friday April 16, 2021.